FDA lifts Juul ban amid vaping industry legal battles

Juul products are back on the market as the U.S. Food and Drug Administration reverses its ban, with the Supreme Court set to address vaping regulations soon.

David Ovalle reports for The Washington Post.

In short:

• The FDA has rescinded its June 2022 ban on Juul products due to ongoing court cases and more experience with e-cigarette issues.
• This move returns Juul’s application to pending status but does not grant marketing approval.
• The Supreme Court will soon discuss whether to review conflicting lower court decisions on FDA vaping regulations.

Key quote:

"The FDA has been having a hard time defending its approach to vaping products. The agency has been overwhelmed and sloppy."

— Jonathan H. Adler, professor of administrative law at Case Western Reserve University

Why this matters:

This decision could impact public health, particularly youth vaping rates, and influence future FDA regulations on e-cigarettes. Read more: People puffing e-cigs are more likely to have heart attacks, strokes and depression.